| Members |
acceptabilityId |
| 29 (qualifier value) |
Preferred (foundation metadata concept) |
| 290 |
Preferred (foundation metadata concept) |
| 290 (qualifier value) |
Preferred (foundation metadata concept) |
| 291.667 |
Preferred (foundation metadata concept) |
| 291.667 (qualifier value) |
Preferred (foundation metadata concept) |
| 29E |
Preferred (foundation metadata concept) |
| 29G |
Preferred (foundation metadata concept) |
| 29G (qualifier value) |
Preferred (foundation metadata concept) |
| 2A (AJCC) |
Acceptable (foundation metadata concept) |
| 2A (UICC) |
Acceptable (foundation metadata concept) |
| 2A1 (AJCC) |
Acceptable (foundation metadata concept) |
| 2A1 (UICC) |
Acceptable (foundation metadata concept) |
| 2A2 (AJCC) |
Acceptable (foundation metadata concept) |
| 2A2 (UICC) |
Acceptable (foundation metadata concept) |
| 2B (AJCC) |
Acceptable (foundation metadata concept) |
| 2B (UICC) |
Acceptable (foundation metadata concept) |
| 2C (AJCC) |
Acceptable (foundation metadata concept) |
| 2C (UICC) |
Acceptable (foundation metadata concept) |
| 2D (two dimensional) external beam radiation therapy involves dose calculation without projection onto 3D imaging and delivered without 3D techniques. |
Preferred (foundation metadata concept) |
| 2D (two dimensional) external beam radiotherapy |
Acceptable (foundation metadata concept) |
| 2D (two dimensional) mode ultrasound - action |
Preferred (foundation metadata concept) |
| 2D-EBRT - two dimensional external beam radiation therapy |
Acceptable (foundation metadata concept) |
| 2E (AJCC) |
Acceptable (foundation metadata concept) |
| 2E (UICC) |
Acceptable (foundation metadata concept) |
| 2H post 100 g glucose PO |
Acceptable (foundation metadata concept) |
| 2H post 75 g glucose PO |
Acceptable (foundation metadata concept) |
| 2H post dose glucose |
Acceptable (foundation metadata concept) |
| 2H post incubation |
Acceptable (foundation metadata concept) |
| 2H post meal |
Acceptable (foundation metadata concept) |
| 2H post peritoneal dialysis |
Acceptable (foundation metadata concept) |
| 2H specimen |
Acceptable (foundation metadata concept) |
| 2H4 |
Acceptable (foundation metadata concept) |
| 2a |
Preferred (foundation metadata concept) |
| 2a (qualifier value) |
Preferred (foundation metadata concept) |
| 2b |
Preferred (foundation metadata concept) |
| 2b (qualifier value) |
Preferred (foundation metadata concept) |
| 2g protein exchanges/day |
Preferred (foundation metadata concept) |
| 2g protein exchanges/day (qualifier value) |
Preferred (foundation metadata concept) |
| 2g protein exchanges/kg body weight |
Preferred (foundation metadata concept) |
| 2g protein exchanges/kg body weight (qualifier value) |
Preferred (foundation metadata concept) |
| 2g protein exchanges/meal |
Preferred (foundation metadata concept) |
| 2g protein exchanges/meal (qualifier value) |
Preferred (foundation metadata concept) |
| 2nd |
Acceptable (foundation metadata concept) |
| 2nd HiB and DTP vaccine given |
Preferred (foundation metadata concept) |
| 2nd HiB and DTP vaccine given (situation) |
Preferred (foundation metadata concept) |
| 2nd Hib and DTP vaccine given |
Preferred (foundation metadata concept) |
| 2nd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
| 2nd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
| 2nd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
| 2nd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
| 2nd floor |
Acceptable (foundation metadata concept) |
| 2nd heart sound split |
Acceptable (foundation metadata concept) |
| 2nd hepatitis A junior vaccination |
Acceptable (foundation metadata concept) |
| 2nd left lumbar vein |
Acceptable (foundation metadata concept) |
| 2nd right lumbar vein |
Acceptable (foundation metadata concept) |
| 2nd specimen |
Acceptable (foundation metadata concept) |
| 2nd stage of labor length |
Preferred (foundation metadata concept) |
| 2nd stage of labor length |
Acceptable (foundation metadata concept) |
| 2nd stage of labour length (observable entity) |
Preferred (foundation metadata concept) |
| 2nd trimester |
Acceptable (foundation metadata concept) |
| 2p partial trisomy syndrome |
Preferred (foundation metadata concept) |
| 2p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2p13.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2p13.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2p15p16.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2p15p16.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2p15p16.1 microdeletion syndrome is a recently described syndrome characterized by developmental delay and facial dysmorphism. |
Preferred (foundation metadata concept) |
| 2p21 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2p21 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2p21 microdeletion syndrome without cystinuria |
Preferred (foundation metadata concept) |
| 2p21 microdeletion syndrome without cystinuria (disorder) |
Preferred (foundation metadata concept) |
| 2p21 microdeletion syndrome without cystinuria is a rare partial autosomal monosomy characterized by weak fetal movements, severe infantile hypotonia and feeding difficulties that spontaneously improve with time, urogenital abnormalities (hypospadias or hypoplastic labia majora), global development delay, mild intellectual disability and facial dysmorphism (dolichocephaly, frontal bossing, bilateral ptosis, midface retrusion, open mouth with tented upper lip vermilion). Affected individuals have borderline elevated serum lactate but no cystinuria. |
Preferred (foundation metadata concept) |
| 2q partial trisomy syndrome |
Preferred (foundation metadata concept) |
| 2q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q23.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2q23.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q23.1 microduplication syndrome |
Preferred (foundation metadata concept) |
| 2q23.1 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q23.1 microduplication syndrome is a rare chromosomal anomaly syndrome, resulting from the partial duplication of the long arm of chromosome 2, primarily characterized by global developmental delay, hypotonia, autistic-like features and behavioral problems. Craniofacial dysmorphism (arched eyebrows, hypertelorism, bilateral ptosis, prominent nose, wide mouth, micro/retrognathia) and an affable personality are also commonly associated. Minor digital anomalies (fifth finger clinodactyly and large, broad first toe) have occasionally been reported. |
Preferred (foundation metadata concept) |
| 2q24 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2q24 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q24 microdeletion syndrome is a chromosomal anomaly consisting of a partial long arm deletion of chromosome 2 and characterized clinically by a wide range of manifestations (depending on the specific region deleted) which can include seizures, microcephaly, dysmorphic features, cleft palate, eye abnormalities (coloboma, cataract and microphthalmia), growth retardation, failure to thrive, heart defects, limb anomalies, developmental delay and autism. |
Preferred (foundation metadata concept) |
| 2q31.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2q31.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q31.1 microdeletion syndrome is a well-defined and clinically recognisable syndrome characterized by moderate to severe developmental delay, short stature, facial dysmorphism and variable limb defects. |
Preferred (foundation metadata concept) |
| 2q32q33 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2q32q33 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q33.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 2q33.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 2q37 deletion syndrome |
Acceptable (foundation metadata concept) |
| 2x normal saline 1.8% infusion solution bag |
Acceptable (foundation metadata concept) |
| 2x/wk |
Acceptable (foundation metadata concept) |
| 3 |
Preferred (foundation metadata concept) |
| 3 |
Preferred (foundation metadata concept) |
| 3 (AJCC) |
Acceptable (foundation metadata concept) |
| 3 (UICC) |
Acceptable (foundation metadata concept) |
| 3 (qualifier value) |
Preferred (foundation metadata concept) |
| 3 Buck shot |
Preferred (foundation metadata concept) |
| 3 Buck shot, device |
Acceptable (foundation metadata concept) |
| 3 Buck shot, device (qualifier value) |
Preferred (foundation metadata concept) |
| 3 alpha hydroxycholanic acid |
Acceptable (foundation metadata concept) |
FHIR